These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 24122393

  • 1. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
    Ripoll GV, Garona J, Pifano M, Farina HG, Gomez DE, Alonso DF.
    Breast Cancer Res Treat; 2013 Nov; 142(1):9-18. PubMed ID: 24122393
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.
    Garona J, Sobol NT, Pifano M, Segatori VI, Gomez DE, Ripoll GV, Alonso DF.
    Cancer Res Treat; 2019 Apr; 51(2):438-450. PubMed ID: 29879760
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells.
    Iannucci NB, Ripoll GV, Garona J, Cascone O, Ciccia GN, Gomez DE, Alonso DF.
    Future Med Chem; 2011 Dec; 3(16):1987-93. PubMed ID: 22098349
    [Abstract] [Full Text] [Related]

  • 6. Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
    Garona J, Pifano M, Pastrian MB, Gomez DE, Ripoll GV, Alonso DF.
    Clin Exp Metastasis; 2016 Aug; 33(6):589-600. PubMed ID: 27146156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent.
    Garona J, Pifano M, Ripoll G, Alonso DF.
    Vitam Horm; 2020 Aug; 113():259-289. PubMed ID: 32138951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M, Tahara A, Sugimoto T.
    Biochem Pharmacol; 1997 Jun 01; 53(11):1711-7. PubMed ID: 9264324
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells.
    Pastrian MB, Guzmán F, Garona J, Pifano M, Ripoll GV, Cascone O, Ciccia GN, Albericio F, Gómez DE, Alonso DF, Iannucci NB.
    Mol Med Rep; 2014 Jun 01; 9(6):2568-72. PubMed ID: 24737067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling.
    Kaufmann JE, Iezzi M, Vischer UM.
    J Thromb Haemost; 2003 Apr 01; 1(4):821-8. PubMed ID: 12871421
    [Abstract] [Full Text] [Related]

  • 16. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A, Hoffmann P, Dumas A, Serradeil-le Gal C, Raufaste D, Herbert JM.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):597-602. PubMed ID: 9262320
    [Abstract] [Full Text] [Related]

  • 17. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y, Yamada K, Suzuki T, Wu YP, Kita K, Takahashi S, Ichinose M, Suzuki N.
    Am J Physiol Endocrinol Metab; 2004 Nov 01; 287(5):E970-6. PubMed ID: 15198931
    [Abstract] [Full Text] [Related]

  • 18. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
    Pecori Giraldi F, Marini E, Torchiana E, Mortini P, Dubini A, Cavagnini F.
    J Endocrinol; 2003 Jun 01; 177(3):373-9. PubMed ID: 12773117
    [Abstract] [Full Text] [Related]

  • 19. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
    Marchingo AJ, Abrahams JM, Woodcock EA, Smith AI, Mendelsohn FA, Johnston CI.
    Endocrinology; 1988 Apr 01; 122(4):1328-36. PubMed ID: 2964362
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.